Hypoglycemic APIs are a class of compounds designed to control and treat diabetes, a chronic metabolic disease characterized by hyperglycemia. Protheragen-ING provides a full range of anti-diabetic APIs, covering biguanides, sulfonylureas, thiazolidinediones, dipeptidyl peptidase 4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibition agents and glucagon-like peptide 1 (GLP-1) receptor agonists, etc. These compounds work through different mechanisms to regulate blood sugar levels and improve insulin sensitivity.
Cat | Product Name | Cas | Details | Chemical Structure |
---|---|---|---|---|
API10238218 | Glyburide | 10238-21-8 | View Details | |
API1094617 | β-Nicotinamide Mononucleotide | 1094-61-7 | View Details | |
API1115704 | Metformin Hydrochloride | 1115-70-4 | View Details | |
API117395 | Quercetin | 117-39-5 | View Details | |
API29094619 | Glipizide | 29094-61-9 | View Details | |
API850649626 | Alogliptin benzoate | 850649-62-6 | View Details | |
API910463682 | Semaglutide | 910463-68-2 | View Details | |
API929207294 | Lanthanum carbonate hydrate | 929207-29-4 | View Details |
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed